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Abstract
Background: Tracing stable isotopes, such as 13C using various mass spectrometry (MS) methods provides a
valuable information necessary for the study of biochemical processes in cells. However, extracting such
information requires special care, such as a correction for naturally occurring isotopes, or overlapping mass spectra
of various components of the cell culture medium. Developing a method for a correction of overlapping peaks is
the primary objective of this study.
Results: Our computer program-MIDcor (free at https://github.com/seliv55/mid_correct) written in the R
programming language, corrects the raw MS spectra both for the naturally occurring isotopes and for the
overlapping of peaks corresponding to various substances. To this end, the mass spectra of unlabeled metabolites
measured in two media are necessary: in a minimal medium containing only derivatized metabolites and chemicals
for derivatization, and in a complete cell incubated medium. The MIDcor program calculates the difference (D)
between the theoretical and experimentally measured spectra of metabolites containing only the naturally
occurring isotopes. The result of comparison of D in the two media determines a way of deciphering the true
spectra. (1) If D in the complete medium is greater than that in the minimal medium in at least one peak, then
unchanged D is subtracted from the raw spectra of the labeled metabolite. (2) If D does not depend on the
medium, then the spectrum probably overlaps with a derivatized fragment of the same metabolite, and D is
modified proportionally to the metabolite labeling. The program automatically reaches a decision regarding the
way of correction. For some metabolites/fragments in the case (2) D was found to decrease when the tested
substance was 13C labeled, and this isotopic effect also can be corrected automatically, if the user provides a
measured spectrum of the substance in which the 13C labeling is known a priori.
Conclusion: Using the developed program improves the reliability of stable isotope tracer data analysis.
Keywords: 13C labeling of metabolites, Gas chromatography/mass spectrometry, Correction of peaks overlapping,
Isotopic effect, Computational analysis, R-program
Background
Metabolic flux analysis based on the incorporation of
13C, originated from artificially enriching 13C into the
metabolites of central carbohydrate metabolism, is now
a widely applied method of investigation providing ac-
cess to the regulation of metabolism in living cells [1–9].
Gas chromatography coupled to mass spectrometry
(GC/MS) is a basic technique used for monitoring 13C
isotopic isomers (isotopomers) that are different in their
mass number (mass isotopomers). In October 2012, the
European COordination of Standards in MetabOlomicS
(COSMOS) consortium, comprising 14 European part-
ners, started its work on metabolomics data
standardization, publication and dissemination work-
flows. The algorithms presented here, prepared in the
framework of this project, were developed with the
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objective to provide a growing database i) with reliable
curated data and ii) computer tools for the initial step of
data analysis.
The artificial 13C labels cannot be distinguished from
various isotopes occurring in the environment and re-
corded by GC/MS as an increase of the mass of the ana-
lyzed molecules. These molecules are the chemical
derivates of metabolites created by chemical binding of
the metabolite molecules to other reagents to produce a
form suitable for GC/MS recording (see Methods sec-
tion for details). Electronic ionization applied for GC/
MS analysis may result in splitting the derivates into
fragments that may contain fragments of the metabolites
designated for testing. The measured mass isotopomer
distribution (MID) should be corrected for the naturally
occurring isotopes to reveal the distribution of only the
artificial 13C labels, which is necessary for subsequent
fluxomic analysis. Methods of the correction for the nat-
urally occurring isotopes 13C and 15N in an analyzed me-
tabolite were first developed by Brauman [10], based on
calculations of the theoretical natural MID using the ob-
served frequencies of the isotopes in the environment
and chemical compositions of assayed molecules. Vari-
ous modifications of this method were developed, e.g.,
[11–14]. Some derivates contain Si, which in addition to
the most abundant isitope 28Si, has substantial fractions
of 29Si and 30Si [15, 16]. Recently published algorithms
[17] allow mass spectra of derivatized metabolites to be
easily corrected for naturally occurring isotopes such as
57Fe and 77Se. However, despite the well-developed cor-
rection schemes for naturally occurring isotopes, the
correction of raw MID data still needs improvements.
The measured MID can differ from the corresponding
calculations that account for the presence of naturally
occurring isotopes. As summarized in [17], the existing
algorithms treat the observed difference formally as
noise, not considering its causes. The objective of pre-
senting here an algorithm for raw MID data correction
is to provide a tool, which, in addition to correcting for
natural isotope occurrence, corrects the data in cases
where mass peaks in a mass spectrum overlap with those
for other metabolites. Overlapping MS signals for more
than one metabolite is an important cause of differences
between experimentally measured and corresponding
MID calculated theoretically. We distinguish two such
an overlapping cases: either 1) with patterns of unlabeled
molecules, which depends only on the composition of
the assay medium, or 2) with another pattern of mass
isotopomers of the same molecules designated for test-
ing, which depends on their artificial labeling. Our open
source software MIDcor (https://github.com/seliv55/
mid_correct), developed in the R programming language,
uses the previously described methods for separation of
natural and artificial labeling [10, 11, 13], and, also,
corrects the peaks overlapping either with unlabeled or
labeled metabolites.
Methods
Experimental
Cell culture
Human immortalized fibroblasts BJ (ATCC, Germany)
were cultured in media consisted of DMEM (Gibco) and
Medium 199 (Sigma-Aldrich) in 4:1 proportion contain-
ing 10% FBS (AG Biochrom), 10 mM glucose, 3 mM
glutamine, 1 mM pyruvate, 0.085 mg/mL hygromycin B
(Roche), 0.4 mg/mL puromycin (Sigma-Aldrich) and 1%
antibiotic. In our experiments the passage number never
exceeded 10.
Labeling of metabolites with 13C
Cells were incubated with the tracer-containing medium
(either 10 mM, 50% enriched [1,2-13C2]-glucose or
2 mM, 100% enriched U-13C-glutamine) for 8 and 24 h.
At the end of incubations, the media were collected and
frozen for glucose and amino acids analysis. For the ana-
lysis of intracellular metabolites, dishes were frozen at
-80 °C until starting the analysis.
GC-MS and MID analysis
Cell culture medium Glucose was extracted using ion
exchange chromatography and derivatized to its aldo-
nitrile acetate form [18]. We monitored the ion clus-
ter around the m/z 328 (carbons 1–6 of glucose,
chemical ionization) to find the molar enrichment of
13C. Lactate was extracted and derivatized to its pro-
pylamideheptafluorobutyric form [19, 20]. The m/z
328 (carbons 1–3 of lactate, chemical ionization) was
monitored. The amino acids were extracted using ion
exchange chromatography, derivatized to their n-
trifluoroacetyl-n-butyl ester forms as is [21]. The ion
clusters around m/z 152 and 198 (carbons 2–4 and
2–5 of glutamate, respectively, electron impact
ionization), m/z 228 (carbons 1–2 of glycine, chemical
ionization) and m/z 354 (carbons 1–3 of serine,
chemical ionization) were monitored.
Intracellular metabolites Cells were scraped using
methanol-water. An equivalent volume of chloroform was
then added, and the aqueous phase was collected and
evaporated under airflow for polar intracellular metabolite
analysis. After dissolution in 50 μL of 2% methoxyamine
hydrochloride in pyridine, the tert-butylmethylsilyl deriva-
tive was prepared by adding 30 μL of N-methyl-N-(tert-
butyldimethylsilyl) trifluoroacetamide (MBTSTFA) + 1%
tert-butyldimethylchlorosilane (TBDMCS; Sigma) and in-
cubating at 55 °C for 1 h [22]. We monitored the ion clus-
ters around m/z 459 (carbons 1-6 of citrate, electron
impact ionization), m/z 174 (carbons 1–3 of pyruvate,
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electron impact ionization) and m/z 418 (carbons 1–4 of
aspartate, electron impact ionization).
Mass spectral data were obtained on a 7890A mass spec-
trometer coupled with a 5675C gas chromatograph (Agi-
lent Technologies). The settings are as follows: GC inlet
230 °C, transfer line 280 °C, MS source 230 °C, MS quad
150 °C. An HP-5 capillary column (30 m length, 250 μm
diameter, 0.25 μm film thickness) was used for analysis
of all metabolites.
Theoretical aspects
Calculation of natural 13C distribution
The correction for naturally occurring isotopes requires
calculation of the theoretical MID based on the observed
isotope occurrence in the environment and the chemical
composition of the analyzed derivate of the tested me-
tabolite. The algorithm for calculating the natural iso-
tope distribution, provided in the MIDcor program, uses
commonly accepted method [10–17]. Additional file 1
Text S1 provides the details.
Correction of the H+ loss provoked by electron impact
Although the molecules combined from the isotopes
with smallest mass are expected to give the lightest mass
isotopomers (designated as M), it is normal that a peak
corresponding to the mass of M-1 is registered [13, 23].
Table 1, which provides an example of raw data obtained
with GC/MS, illustrates such a peak.
The isotopomers of M-1 can appear due to H+ loss as
a side effect of an impact of the electron flow used for
ionization of molecules in a GC/MS apparatus. This ef-
fect could result in a systematic error in the experimen-
tal determination of the MID, and the MIDcor program
corrects it. In the example, provided in Table 1, the frac-
tion of M-1 is 0.7% of the peak corresponding to M. The
same portion of H+ loss is assumed for all other mass
isotopomers. This effect decreases the weight of isotopo-
mers and thus shifts them from their proper peak in the
MS recording to a position one mass unit less.
A correction for “shifted” isotopomers, implemented
in the MIDcor program, is based on the calculation of
the ratio of isotopomers (M-1) to (M) in a commercial
preparation of unlabeled metabolite:
f ¼ N M‐1ð Þ=NM ð1Þ
This factor (f ), reflecting the portion of isotopomers
shifted due to H+ loss, should be applied to all peaks
to return the corresponding amounts from (M + i-1)
to (M + i):
NcorrMþið Þ ¼ NmMþið Þ⋅ 1þ fð Þ−NmMþiþ1ð Þ⋅f ð2Þ
Here “m” stand for “measured” and “corr” for “cor-
rected”. After such a correction the measured distribu-
tion is normalized by the sum of all peaks accounted for
in a fragment:
f i ¼ N Mþið Þ=
Xn
k¼0
N Mþkð Þ ð3Þ
Such a normalized distribution of m/z peaks (F = {fi})
is then further corrected for naturally occurring isotopes,
which is necessary to determine the fractions (m) of arti-
ficially labeled isotopomers.
The difference (D) between the theoretical (Pt) and ex-
perimental (Pe) MIDs after the correction of the latter
for H+ loss and normalization was further used to
characterize sources of errors other than H+ loss.
D ¼ Pe‐Pt ð4Þ
Calculated and measured MID
As an example, the MID for aspartate (peaks from M-1
to M + 5) shown in Table 1 was obtained from a cell cul-
ture medium with no 13C labeled substrates. The assayed
derivative fragment contains 18 C and 3 Si atoms. In
theory, such a composition provides 25 possible mass
isotopomers (ranging from unlabeled to maximally la-
beled), but only five mass isotopomers were measurable,
as confirmed by calculations indicating that the fractions
of isotopomers with the higher mass numbers are van-
ishingly small. The natural MID, measured and calcu-
lated as described in Additional file 1 Text S1, corrected
for the mass shift and normalized (Eqs 1-3), is shown in
Fig. 1.
The measured MID (from [M] to [M + 4]) was:
Pe ¼ 0:63218; 0:22691; 0:11163; 0:02367; 0:00562½ 
After the described above correction for the mass shift
and normalization (Eqs 1-3) we have the following MID
(from [M] to [M + 4]):
Pe ¼ 0:6325 0:2271 0:1118 0:0230 0:0056½  ð5Þ
The theoretical distribution that provides values for all
possible 25 mass isotopomers, is reduced to the size of
Table 1 The intensities GC/MS peaks for cold TMS-derivative of aspartate fragment
m/z: 417(M-1) 418(M) 420(M + 1) 420(M + 2) 421(M + 3) 422(M + 4) 423(M + 5)
Sample 1 704 112249 40291 19821 4202 997 97
Sample 2 713 104212 37495 18416 3657 909 47
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the experimental value (5), to make them consistent,
and renormalized to the sum of the remaining
isotopomers:
Pt ¼ 0:6435 0:2266 0:1016 0:0232 0:0051½  ð6Þ
The difference (D) between the calculated and mea-
sured spectra was determined for naturally labeled me-
tabolites in the case considered here:
D ¼ Pe−Pt
¼ −0:01099 0:00052 0:01026 −0:00023 0:00044½ 
ð7Þ
The D-value for the most abundant mass isotopomer
(M), although it is relatively small (~1%), is greater than
the difference between the values of direct measure-
ments in various samples normalized by the sum of
peaks, as shown for a typical example of a series of tech-
nical and biological replicates presented in supplemen-
tary Additional file 2 Text S3.
Obtaining a genuine 13C distribution originating from
artificially labeled substrates
In general, a measured distribution after being corrected
for an H+ loss contains a mixture of naturally occurring
isotopomers and those obtained from artificially labeled
substrates. A correction for naturally occurring isotopes
is necessary to generate a genuine “artificial” 13C distri-
bution, i.e., the one originating from substrates artifi-
cially enriched with the 13C isotope. Here, we briefly
describe the method for implementing such a correction
in the MIDcor program.
First, the program is used to construct a set of vectors
corresponding to the distribution of naturally occurring
isotopes in the absence of artificial labels (P0, equal to Pt
in Eq. (6)), or to the presence of one (P1), two (P2), etc.,
artificial labels in the tested molecules. This set of vec-
tors yields the correction matrix, where the vectors (P0),
P1, …, appear in columns (Table 2).
If, for instance, one artificially labeled carbon is
present in the molecule (P1), then the probability of
finding an unlabeled isotopomer among such molecules
is zero. However, in the molecules containing one artifi-
cial label, a non-zero likelihood exists of finding more
than one 13C carbons due to the natural occurrence of
the 13C isotopes. The other carbons can be 13C-labeled
following the natural occurrence of 13C isotope (renor-
malized each time to the sum of the remaining isotopo-
mers). In general, for any molecule, containing two,
three, etc., artificial labels, the probability of finding
fewer labels is virtually zero, and the probability of find-
ing more labels is determined by the natural occurrence
of 13C isotopes.
To acquire the actual value for artificial labeling, not
mixed with naturally occurring isotopes, it is necessary
to solve the following equation:
m P ¼ Pe ð8Þ
Here P is the matrix presented in Table 2, and Pe is
the vector shown in Eq. (6).
The difference between calculated and measured
distributions
In the example considered here, aspartate molecules
do not contain any artificial 13C labels. In this case,
the distribution corrected for the number of naturally
occurring isotopes should yield a vector m not con-
taining any artificial 13C labels, i.e., m = [1 0 0 0 0].
In fact the solution of Eq. (8) is m = [0.9833 0.0064
0.0159–0.0047–0.0002].
The actual solution is different from the one expected,
because the theoretical MID calculated for naturally oc-
curring isotopes (Eq. 6) is distinct from the correspond-
ing distribution measured experimentally (Eq. 5) by the
vector D (Eq. 7). We suggested that such differences
Fig. 1 Natural MID, measured for cold TMS-derivative of aspartate. The
raw data for two independent samples shown in Table 1 were
corrected for the mass shift and normalized (Eqs 1–3). The calculations
were performed as described in Additional file 1 Text S1
Table 2 A correction matrix for evaluation of “pure” artificial 13C
distribution
P0 P1 P2 P3 P4
m0 0.6435 0 0 0 0
m1 0.2266 0.6468 0 0 0
m2 0.1016 0.2277 0.6623 0 0
m3 0.0232 0.1021 0.2332 0.7396 0
m4 0.0051 0.02333 0.10455 0.26041 1
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between experimental and the corresponding theoretical
distributions often arise from the overlap of the mass
spectrum of an analyzed metabolite with that of another
substance existing in the medium.
Two ways of correcting measured m/z peaks in the
presence of artificial labeling
The correction of the experimental data in the case con-
sidered of unlabeled aspartate by subtracting the vector
D from the experimental data is evident. However, it is
not clear how to correct this kind of errors for the tested
samples with unknown artificial 13C labeling, where the
corresponding theoretical spectra cannot be calculated.
In samples with unknown artificial 13C labeling we cor-
rect the error arising from overlapping peaks based on
the vector D determined for unlabeled samples as de-
scribed above. In this correction we distinguished two
cases: 1) the difference D does not depend on the mea-
sured distribution of artificial label in the assayed metab-
olite, but depends on the composition of the medium
and 2) the difference D depends on the distribution of
the artificial label in the assayed metabolite, mass distri-
butions of various fragments of the same labeled metab-
olite probably overlap in the measured range of m/z.
In case 1 a possible reason for the difference D is an
overlapping of the analyzed peaks in the mass spectrum
with peaks of some compound of the assay medium,
which can be the same for labeled as well as for un-
labeled samples. The correction consists of subtracting
the difference D obtained for the unlabeled sample with-
out its modification from the mass spectrum measured
for the tested labeled sample (Eq. 4 in general, or Eq. 7
for the case of aspartate in the given experiment).
In case 2 the difference (Eq. 4) is valid only for the
naturally labeled metabolite, and the artificial labeling
shifts the difference D by the m/z number correspond-
ing to the number of artificially introduced 13C atoms.
The contribution of any individual artificially labeled
mass isotopomer to the modified D value should be pro-
portional to the fraction of a particular isotopomer.
Variation of the composition of the assay medium al-
lows for distinguishing between these two causes of in-
consistency. To this end, the m/z distribution for the
given metabolite not labeled artificially should be mea-
sured both (a) in the full medium in which the cell was
incubated and (b) in the solution containing only the
tested metabolite and reagents used for the
derivatization.
If the evaluated difference D (Eq. 4) is greater in the
medium (a) than in (b), the cause of the observed dis-
crepancy D is overlapping of the analyzed pattern with
that for some metabolite of the incubation medium
(case 1). D should be subtracted from the measured
normalized spectrum without any change, following
Eq. 4, to correct the raw data in this case.
If D is equal in both the medium (a) and in (b), the in-
cubation medium does not affect the measurement. In
this case, the analyzed mass spectrum probably overlaps
with a pattern of another fragment of the same metabol-
ite, which is present in the medium (a) as well as in (b).
Therefore the independence of D from the medium of
incubation characterizes case 2. D should be modified
considering that labeling with n 13C isotopes shifts D by
n positions to the right and the values of D change pro-
portionally to the enrichment in (M + n) isotopomers.
Such a modification is implemented as follows.
Correction of measured m/z distribution (F0) for the case
in which D depends on the artificial labeling of the
assayed metabolite
Step 1
Calculate the MID, correcting the measured Pe only for
H+ loss and for naturally occurring isotopes, as de-
scribed in Methods.
Step 2
Recalculate D for the MID obtained by assuming the
presence of each artificially introduced 13C atom shifts
the vector D, determined for the unlabeled sample, by
one m/z unit and changes proportionally to the intensity
of labeling.
Step 3
Obtain a new vector Pe, by adding the vector D, recalcu-
lated in Step 2, to the experimental distribution follow-
ing Eq. 4; return to Step 1,
The cycle for step 1-step 3 repeats until the vector F
and the corresponding distribution of artificially labeled
isotopomers m stabilizes.
Results and discussion
Difference D for some metabolites
The difference between the relative values of corre-
sponding peaks for two technical replicates, calculated
based on the data shown in Table 1, is less than 0.03%,
and in general, in our laboratory the standard deviation
of repeated technical replicates is less than 0.5%. This
value characterizes the sensitivity of the method. Table 3
shows the values of the difference D (Eq. 8) for some
metabolites in the incubation medium (conditions (a))
and the minimal medium containing only the compo-
nents necessary for derivation (conditions (b)). The ob-
tained deviation from theoretical distribution for most of
the tested metabolites in both conditions overcome the
sensitivity of the method, as indicated by the values of D
for various metabolites shown in Table 3. Such a big
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difference points that there is an additional source of er-
rors that we do not take into consideration.
The two measurements for each analyzed metabolite
shown in Table 3 are sufficient to verify which one of
the two cases determines the value of the correction. In
principle, the measurements in a minimal medium can
be performed just once, and they can serve for all subse-
quent experiments analyzed using the specific GC/MS
instrument. In this case, only the measurement of the
mass spectra of unlabeled metabolites in the specific cell
incubation medium is necessary.
As presented in Table 3, both cases considered above
probably occur. The discrepancy between the measured
and predicted labeling in glucose and glycine increases
when passing from the minimal solution (b) to the cell
incubation medium (a). This increase is consistent with
case 1: the m/z values of some components of the
medium overlap with the m/z values of a metabolite-of-
interest when the artificial labeling is analyzed. Because
the composition of the medium does not depend on the
labeling of the assayed metabolite, the value D, calcu-
lated for the unlabeled sample, should be added to the
measured vector Pe without any change.
On the contrary, in the other cases, the difference does
not change if the medium changes. The value of D for the
glutamate fragment C2–C4 is huge, but it is the same in
both media. An unexpected M+ 1 peak appears in this
fragment. The constant D is consistent with case 2: the
m/z pattern of the assayed fragment overlaps with some
other fragment of the same metabolite, such that labeling
changes the overlapping patterns. In this case, the above-
described correction algorithm should be applied.
If the difference D is determined by the composition
of the medium, rather than by the artificial labeling of
the assayed metabolite, the correction is simple and in-
tuitive. However, in the case in which D depends on the
artificial labeling of the assayed metabolite, the algorithm
for data correction must be validated, and an example of
such a validation is described next.
Validation of the algorithm for correction of the
measured MID in the case of natural and uniformly
labeled C2-C4 fragments of glutamate
The difference D in the case of the C2-C4 fragment of
glutamate (Table 2), as concluded above, depends on the
artificial labeling of this fragment. Artificial labeling is
expected to shift D to the right by the number of labeled
carbons present in the carbon skeleton. Therefore, it
should be corrected using the above-described algo-
rithm. To validate this conclusion, we analyzed the m/z
values for spectra measured for artificially labeled com-
mercially available glutamate. The intensities of the
peaks corresponding to the mass isotopomers of the C2-
C4 fragment of the trifluoroacetamide butyl ester of glu-
tamate are shown in Table 4.
Table 5 demonstrates the distribution of mass isotopo-
mers after the correction for the occurrence of natural
isotopes, and normalization. After this correction, a sig-
nificant but unexpected fraction of the m0 + 1 isotopo-
mer was detected in the unlabeled sample. In the sample
containing only one 13C atom per molecule, a significant
fraction of an unexpected m1 + 1 isotopomer was de-
tected. In the uniformly labeled sample in which all
three carbons of the C2–C4 fragment were labeled, the
Table 3 The differences (D, Eq. 4, expressed as % of total amount of a substance) between calculated and measured MID for some
TMS derivatives of metabolites
m/z: M M + 1 M + 2 M + 3 M + 4 M + 5 M + 6 Max df,case#
glucose −0.35 −0.62 0.94 0.02 0.00 0.00 0.00 2.25
+medium −2.60 0.64 1.60 0.26 0.06 0.01 0.00 case 1
Glu (2–4) −9.30 7.74 1.33 0.21 nd nd nd −0.10
+medium −9.20 7.79 1.23 0.22 nd nd nd case 2
Glu (2–5) −1.30 0.48 0.65 0.04 0.14 nd nd 0.10
+medium −1.40 0.51 0.65 0.04 0.18 nd nd case 2
Aspartate −0.98 −0.06 0.88 0.14 0.02 0.00 nd 0.12
+medium −1.10 0.05 1.03 −0.02 0.04 nd nd case 2
serine −0.70 −0.37 0.87 0.13 nd nd nd 0.40
+medium −1.10 0.02 0.91 0.17 nd nd nd case 2
glycine −0.50 −0.14 0.57 0.08 0.01 nd nd 0.70
+medium −1.20 0.27 0.70 0.23 0.01 nd nd case 1
The first row for each metabolite was calculated using Eq. 4 for the measurements in the minimal solution for derivatization (conditions (b), see 3.1.4). The next
row indicated as “+medium” was calculated for the measurements in the complete media for cell incubation (conditions (a)). “Glu (2–4)” and “Glu (2–5)” refer to
the fragments C2-C4 and C2-C5 of glutamate after ionization in the mass spectrometer, “nd” stands for “not determined”. The right column indicates the maximal
difference between the two rows for each metabolite, and, based on this difference and using a threshold value of 0.5%, recommendation to analyze it in accordance
with case 1 or case 2
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unexpected fraction of m3 + 1 was detected. Indeed, the
m/z position of the unexpected isotopomer shifts and is
always situated next to the position of the most abun-
dant isotopomer. Such a labeling-dependent shift quali-
tatively confirms the assumption that the unexpected
peak is produced by some derivate of the same labeled
metabolite.
However, the value of such unexpected peak for the
artificially labeled fragment is not the same as for un-
labeled one. The corresponding correction following the
correction algorithm resulted in the mass isotopomer
distributions shown in Table 6.
After correction for the occurrence of the natural iso-
tope, the algorithm for the correction was applied to the
case of the analyzed overlapping pattern with another
that depends on the labeling of the studied metabolite.
The quantitative difference between the values of the
unexpected peak for the unlabeled metabolite leads to
the negative value of approximately 4% for the next-to-
the-most abundant mass isotopomer (by mass number).
Isotopic effects can explain this quantitative difference
from the expected values-as isotopic enrichment in-
creases, the probability of forming an overlapping frag-
ment decreases. Our hypothesis relative to the nature of
the isotopic effect is described in the Additional file 3
Text S2. Because this effect is approximately the same
for the fragment labeled in just one position, C3, and for
the completely labeled fragment, one could conclude
that the isotope in the C3 position determines this iso-
topic effect. Such an isotopic effect was implemented
such that D determined for the unlabeled substance was
applied only for the unlabeled fraction, whereas if it is
applied to the labeled fractions, D should be multiplied
by some factor. This isotopic factor represents a value
that, applied to the vector D, allows the known labeling
in commercial preparations to be reproduced.
Application of such a differential correction with an
isotopic factor of approximately 0.6 allows the known la-
beling of the isotopomers to be reproduced as shown in
Table 7. Subsequently, when the isotopic effect is known
and considered, the software can be applied to correct
the unknown distribution of mass isotopomers. As an
example of “unknown” labeling, the mass spectra of vari-
ous mixtures of commercial samples of unlabeled com-
pounds, and Q3-13C and QU-13C isotopomers, were
measured. The results of this determination were con-
sistent with the prepared mixtures (Table 7).
The electron impact ionization procedure used in GC/
MS produces various fragments of glutamate (e.g., a
fragment, C2–C5 in addition to C2–C4). The values of
D corresponding to the C2–C5 fragment are much less
than those for the C2–C4 fragment (Table 3). Mass dis-
tribution measurements are also used to determine the
glutamate labeling. The fractions determined based on
the mass distribution of the C2–C5 fragment are also
presented in Table 7. The corrections applied produce
the same results for both fragments, although the devi-
ation of the measured from the expected mass isotopo-
mer distribution (vector D) for the C2–C4 fragment is
much larger than that for the C2–C5 fragment. Thus,
the applied algorithm yields the correct fractions of the
mixtures of commercial glutamine preparations based
on the mass distribution either in fragment C2–C4,
characterized by large values of D, or characterized by a
relatively small value for D in the C2-C5 fragment.
Thus, the validation of our algorithm for the correc-
tion of overlapping peaks for Glu fragment C2–C4 re-
vealed that although the artificial labeling shifts the
vector D as in case 2, it also changes the values of D
proportionally. Because the change in D depends on the
isotopic composition we termed it an “isotopic effect.”
We did not study here the actual nature of this effect;
this term simply represents the change in D determined
by artificial labeling. The isotopic effect can be
Table 4 Intensities of GC/MS peaks in C2-C4 fragment of glutamate for various commercially available isotopomers
m/z 151 152 153 154 155 156 157 158 159
natural 6293 712362 110422 12185 1821 3166 528 8002 877
Q3-13C 1562 10455 652415 63645 8745 1225 2767 386 4340
QU-13C 315 2406 3923 24427 833038 64103 9910 838 484
Here “Q3-13C” states for the sample where only one 13C is introduced in position 3, and “QU-13C” states for uniformly 13C labeled sample
Table 5 Data shown in Table 4 after a correction for natural
isotope occurrence and normalization
m0 m1 m2 m3 m4
natural 0.90 0.09 0.01 0.0 0.0
Q3-13C 0.004 0.935 0.049 0.01 0.001
QU-13C 0.003 0.004 0.016 0.927 0.050
The names of the commercial preparations analyzed are the same as
in Table 4
Table 6 The fully corrected artificial labeling of C2-C4 fragment
of glutamate
m0 m1 m2 m3 m4
natural 1.0 0.0 0.0 0.0 0.0
Q3-13C 0.005 1.037 −0.044 0.002 0.
QU-13C 0.003 0.004 0.018 1.011 −0.036
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quantified by a factor that, being multiplied by D, allows
the measured MID to be reproduced in the presence of
artificial labeling. Once determined by fitting a sample
with a priori known artificial labeling, it can be validated
by the calculation of labeling of other known samples
using the algorithm described here, and the factor deter-
mined. Here, we determined the value of the “isotopic”
factor as 0.6 by fitting the known MID in the C2–C4
fragment of commercial 3-13C-Gln (Table 7). Subse-
quently, we validated this factor by calculating the MID
in U-13C-Gln and in three other samples presented in
Table 7. The agreement of the calculations with the
known MID, as well as with the results of analysis of an-
other fragment, C2–C5, allows us to conclude that the
applied method of correction is valid, although the ac-
tual nature of this effect should be further investigated.
The considered here examples show that more than one
substance can commonly have mass spectra in the same
m/z region. Such overlapping of an analyzed metabolite
mass spectrum with that of another substance hides the
actual distribution of isotopes, originating from artificially
13C enriched substrates. Our computer program MIDcor
corrects the errors arising from such an overlapping. It
implements an algorithm that supports two cases of cor-
rection based on D, obtained in two different media-in a
full cell incubation medium, and in a minimal medium
prepared with only the assayed metabolite and reactants
for derivation. If some values of the vector D obtained in
the complete medium are larger than the corresponding
values of D for the minimal medium by > 0.5%, then, the
MIDcor program applies case 1: subtracting the non-
modified D from the normalized spectra of samples
designed for testing before their correction for naturally
occurring isotopes. If D is the same in both media, then
the MIDcor program applies the algorithm appropriate
for case 2: modifying D by shifting it to the right on the
m/z scale by the number of artificial isotopes present and
changing it proportionally to the fractions of the corre-
sponding mass isotopomers.
In case 2, the correction, applied to a sample with a
priori known artificial labeling allows determining the
isotopic effect, defined as a change of D values induced
by substitution of some of the 12C atoms in the carbon
skeleton of a molecule by 13C atoms.
Conclusions
The MIDcor program reveals the distribution of 13C mass
isotopomers originating exclusively from artificially 13C
enriched substrates. It corrects the raw mass spectrum of
a considered metabolite (1) for the occurrence of the nat-
ural isotopes, and (2) for possible overlapping with mass
spectra of other substances. Whereas the former is a
standard procedure implemented in various computer
programs, the latter is specific to our algorithm. To cor-
rect the peaks overlapping MIDcor calculates the theoret-
ical mass isotopomer distribution for the case of only
naturally occurring isotopes. Then it finds differences (D)
of the calculated distribution from that measured without
artificial labeling either in the complete medium of cell in-
cubation or in minimal medium containing only products
of the metabolite derivatization. Values in vector D > 1%
are considered to indicate overlapping peaks. If D is sig-
nificantly greater in full than in minimal medium, we con-
clude that the considered spectrum overlaps with that of
another substance presented only in full medium. If D is
similar in both media, the considered spectrum overlaps
with that of another derivate of the studied metabolite,
presented in both media. Based on the determined D,
MIDcor corrects the peaks overlapping in any artificially
13C labeled samples, treating these two cases differently. If
the metabolite labeling changes the probability of peaks
overlapping, a spectrum of the metabolite with a priori
known artificial labeling should be fit. The usage instruc-
tions together with the code can be found at https://
github.com/seliv55/mid_correct.
Additional files
Additional file 1: Text S1.pdf. Calculation of natural 13C distribution.
(PDF 58 kb)
Additional file 2: Text S3.pdf. An example of standard deviations in a
series of technical and biological replicates. (PDF 65 kb)
Additional file 3: Text S2.pdf. Proposed fragment, which overlap with
glutamate C2-C4 in GC/MS spectra. (PDF 926 kb)
Table 7 Accounting for the isotopic effect in data correction for
C2-C4 and C2-C5 fragments of glutamine using the factor of 0.6
for the labeled isotopomers
13C-labeling m0 m1 m2 m3 m4 fragment
natural 1 0 0 0 0 C2C4
natural 1 0 0 0 0 C2C5
3-13C-Gln 0.008 0.986 0.0 0.005 0 C2C4
3-13C-Gln 0.005 0.9895 0.001 0.003 0.001 C2C5
U-13C-Gln 0.004 0.005 0.018 0.973 0 C2C4
U-13C-Gln 0.003 0.003 0.01 0.022 0.959 C2C5
n:3:U_90:2:8 0.889 0.020 0.002 0.089 0 C2C4
n:3:U_90:2:8 0.888 0.021 0.001 0.002 0.088 C2C5
n:3:U_40:30:30 0.437 0.277 0.006 0.280 0 C2C4
n:3:U_40:30:30 0.436 0.277 0.003 0.007 0.276 C2C5
n:3:U_95:2:3 0.940 0.026 0.001 0.032 0.0 C2C4
n:3:U_95:2:3 0.940 0.027 0.0 0.001 0.032 C2C5
The calculated artificial labeling of naturally or artificially 13C labeled C2–C4
and C2–C5 fragments of glutamine was obtained by applying the algorithm
modified to account for the isotopic effect. The samples were prepared either
from unlabeled glutamine (natural), 13C- glutamine labeled at position 3
(3-13C-Gln), uniformly labeled glutamine (U-13C-Gln), or various ratios of
these samples: natural : 3-13C-Gln : U-13C-Gln (n:3:U) as indicated
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